⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Official Title: A Double-blind, Randomized Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Subjects With Metastatic Breast Cancer

Study ID: NCT01516307

Study Description

Brief Summary: The purpose of this study is to compare active immunotherapy (OPT-822/OPT-821) with PBS in combination with low dose cyclophosphamide, in post-treated metastatic breast cancer subjects with stable disease or response to treatment.

Detailed Description:

Keywords

Eligibility

Minimum Age: 21 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

The University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States

St. Jude Heritage Healthcare, Virginia K. Crosson Cancer Center, Fullerton, California, United States

University of California, San Diego (UCSD), La Jolla, California, United States

University of California, Irvine (UCI), Orange, California, United States

University of California, San Francisco (UCSF), San Francisco, California, United States

Coastal Integrative Cancer Care, San Luis Obispo, California, United States

Central Coast Medical Oncology Corporation, Santa Maria, California, United States

University of California, Los Angeles (UCLA), Santa Monica, California, United States

Memorial Regional Hospital, Hollywood, Florida, United States

University of Chicago Medical Center, Chicago, Illinois, United States

Weill Cornell Medical College, New York, New York, United States

Hope Women's Cancer Center, Asheville, North Carolina, United States

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

UNIMED Medical Institute, Hong-Kong, , China

HCG, Bangalore Institute of Oncology, Bengaluru, , India

Curie Manavata Cancer Centre, Mumbai, , India

Pusan National University Hospital, Busan-si, , Korea, Republic of

Dong-A University Hospital, Busan, , Korea, Republic of

Inha University Hospital, Chungcheongbuk-Do, , Korea, Republic of

National Cancer Center, Chungcheongbuk-Do, , Korea, Republic of

Kyungpook National University Medical Center, Daegu, , Korea, Republic of

Yeungnam University Medical Center, Daegu, , Korea, Republic of

Asan Medical Center, Seoul, , Korea, Republic of

Korea University Anam Hospital, Seoul, , Korea, Republic of

Seoul National University Hospital ,, Seoul, , Korea, Republic of

Seoul St. Mary's Hospital, Seoul, , Korea, Republic of

Severance Hospital, Seoul, , Korea, Republic of

Changhua Christian Hospital, Changhua, , Taiwan

Kaohsiung Medical University Hospital, Kaohsiung City, , Taiwan

Kaohsiung Veterans General Hospital, Kaohsiung City, , Taiwan

Chang Gung Memorial Hospital-KS, Kaohsiung, , Taiwan

Chang Gung Memorial Hospital -Linkou, Linkou, , Taiwan

Mackay Memorial Hospital, New Taipei City, , Taiwan

China Medical University Hospital, Taichung, , Taiwan

Taichung Veterans General Hospital, Taichung, , Taiwan

Chi Mei Medical Center, Tainan City, , Taiwan

National Cheng Kung University Hospital, Tainan, , Taiwan

Koo Foundation Sun Yat-Sen Cancer Center, Taipei City, , Taiwan

Taipei Veterans General Hospital, Taipei City, , Taiwan

Chang Gung Memorial Hospital-Taipei, Taipei, , Taiwan

National Taiwan University Hospital, Taipei, , Taiwan

Shuang-Ho Hospital, Taipei, , Taiwan

Tri-Service General Hospital, Taipei, , Taiwan

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: